Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -146.30% is 376% below its 5-year average of -30.73%, near the low end of its 5-year range (-146.30%–-12.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 49.73% below its 12-month average of -97.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -146.30%.
RETURN ON INVESTED CAPITAL (ROIC)
-146.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-97.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-45.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-30.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-80.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-80.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-49.73%
CURRENT VS 3Y AVG
-219.39%
CURRENT VS 5Y AVG
-375.99%
CURRENT VS 10Y AVG
-81.63%
CURRENT VS 15Y AVG
-82.15%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-25.58%
median of 378 covered companies
CURRENT VS SECTOR MEDIAN
-472.02%
vs the sector median at left
Atossa Therapeutics, Inc.
Market Cap
$24.44M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-97.71%
3Y Avg
-45.80%
5Y Avg
-30.73%
Market Cap
$25.48M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-80.89%
3Y Avg
-129.43%
5Y Avg
-113.96%
Market Cap
$21.90M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$20.93M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
Market Cap
$28.43M
Return on Invested Capital (ROIC)
-109.29%
TTM Avg
-89.70%
3Y Avg
-72.19%
5Y Avg
-61.37%
Market Cap
$18.82M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$18.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$30.65M
Return on Invested Capital (ROIC)
-135.73%
TTM Avg
-98.73%
3Y Avg
-101.28%
5Y Avg
-89.83%
Market Cap
$30.92M
Return on Invested Capital (ROIC)
-126.84%
TTM Avg
-48.51%
3Y Avg
-88.12%
5Y Avg
-74.86%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $24.44M | -146.30% | -97.71% | -45.80% | -30.73% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -53.34% | -80.89% | -129.43% | -113.96% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -14.21% | -12.54% | -12.42% | -37.50% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -109.29% | -89.70% | -72.19% | -61.37% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -46.69% | -40.71% | -34.73% | -24.39% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -171.06% | -106.73% | -106.73% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -135.73% | -98.73% | -101.28% | -89.83% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -126.84% | -48.51% | -88.12% | -74.86% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -50.66% | -13.98% | 7.71% | 25.88% |
ROIC
-146.3%
ROE
-140.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -146.30% |
| 2026-03-31 | -129.89% |
| 2025-12-31 | -94.38% |
| 2025-09-30 | -65.99% |
| 2025-06-30 | -51.98% |
| 2025-03-31 | -42.95% |
| 2024-12-31 | -38.64% |
| 2024-09-30 | -40.02% |
| 2024-06-30 | -38.14% |
| 2024-03-31 | -36.45% |
| 2023-12-31 | -34.48% |
| 2023-09-30 | -31.04% |
| 2023-06-30 | -29.78% |
| 2023-03-31 | -26.52% |
| 2022-12-31 | -23.47% |
| 2022-09-30 | -19.68% |
| 2022-06-30 | -16.37% |
| 2022-03-31 | -16.08% |
| 2021-12-31 | -14.86% |
| 2021-09-30 | -14.09% |
| 2021-06-30 | -12.68% |
| 2021-03-31 | -10.88% |
| 2020-12-31 | -53.72% |
| 2020-09-30 | -131.67% |
| 2020-06-30 | -151.90% |
| 2020-03-31 | -147.60% |
| 2019-12-31 | -131.02% |
| 2019-09-30 | -111.47% |
| 2019-06-30 | -95.40% |
| 2019-03-31 | -69.75% |
| 2018-12-31 | -129.86% |
| 2018-09-30 | -102.90% |
| 2018-06-30 | -70.92% |
| 2018-03-31 | -140.22% |
| 2017-12-31 | -103.83% |
| 2017-09-30 | -319.16% |
| 2017-06-30 | -274.00% |
| 2017-03-31 | -491.24% |
| 2016-12-31 | -262.57% |
| 2016-09-30 | -149.27% |
| 2016-06-30 | -430.09% |
| 2016-03-31 | -313.13% |
| 2015-12-31 | -341.32% |
| 2015-09-30 | -150.31% |
| 2015-06-30 | -99.09% |
| 2015-03-31 | -126.44% |
| 2014-12-31 | -127.09% |
| 2014-09-30 | -76.16% |
| 2014-06-30 | -64.95% |
| 2014-03-31 | -52.83% |
| 2013-12-31 | -101.73% |
| 2013-09-30 | -69.57% |
| 2013-06-30 | -68.38% |
| 2013-03-31 | -60.85% |
| 2012-12-31 | -65.02% |
| 2012-09-30 | -124.23% |
| 2012-03-31 | -509.86% |
| 2011-12-31 | -133.70% |
| 2011-09-30 | -69.27% |
